Free Trial
NYSE:LH

Labcorp (LH) Stock Price, News & Analysis

Labcorp logo
$259.45 +2.00 (+0.78%)
Closing price 03:56 PM Eastern
Extended Trading
$257.56 -1.89 (-0.73%)
As of 06:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Labcorp Stock (NYSE:LH)

Key Stats

Today's Range
$256.85
$260.01
50-Day Range
$241.26
$264.18
52-Week Range
$198.96
$265.72
Volume
527,493 shs
Average Volume
642,200 shs
Market Capitalization
$21.72 billion
P/E Ratio
29.99
Dividend Yield
1.11%
Price Target
$277.75
Consensus Rating
Moderate Buy

Company Overview

Labcorp Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
89th Percentile Overall Score

LH MarketRank™: 

Labcorp scored higher than 89% of companies evaluated by MarketBeat, and ranked 113th out of 921 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Labcorp has received a consensus rating of Moderate Buy. The company's average rating score is 2.79, and is based on 10 buy ratings, 2 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Labcorp has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Labcorp's stock forecast and price target.
  • Earnings Growth

    Earnings for Labcorp are expected to grow by 9.56% in the coming year, from $16.01 to $17.54 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Labcorp is 29.99, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.92.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Labcorp is 29.99, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.05.

  • Price to Earnings Growth Ratio

    Labcorp has a PEG Ratio of 1.63. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Labcorp has a P/B Ratio of 2.70. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Labcorp's valuation and earnings.
  • Percentage of Shares Shorted

    4.13% of the float of Labcorp has been sold short.
  • Short Interest Ratio / Days to Cover

    Labcorp has a short interest ratio ("days to cover") of 4.3.
  • Change versus previous month

    Short interest in Labcorp has recently increased by 10.61%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Labcorp pays a meaningful dividend of 1.12%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Labcorp does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Labcorp is 33.29%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Labcorp will have a dividend payout ratio of 16.42% next year. This indicates that Labcorp will be able to sustain or increase its dividend.

  • Read more about Labcorp's dividend.
  • Percentage of Shares Shorted

    4.13% of the float of Labcorp has been sold short.
  • Short Interest Ratio / Days to Cover

    Labcorp has a short interest ratio ("days to cover") of 4.3.
  • Change versus previous month

    Short interest in Labcorp has recently increased by 10.61%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Labcorp has a news sentiment score of 1.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 22 news articles for Labcorp this week, compared to 14 articles on an average week.
  • Search Interest

    3 people have searched for LH on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.
  • MarketBeat Follows

    Only 2 people have added Labcorp to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Labcorp insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,928,714.00 in company stock.

  • Percentage Held by Insiders

    Only 0.84% of the stock of Labcorp is held by insiders.

  • Percentage Held by Institutions

    95.94% of the stock of Labcorp is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Labcorp's insider trading history.
Receive LH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Labcorp and its competitors with MarketBeat's FREE daily newsletter.

LH Stock News Headlines

What Makes Labcorp (LH) a New Buy Stock - Nasdaq
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
See More Headlines

LH Stock Analysis - Frequently Asked Questions

Labcorp's stock was trading at $229.32 at the start of the year. Since then, LH shares have increased by 13.1% and is now trading at $259.45.

Labcorp Holdings Inc. (NYSE:LH) posted its quarterly earnings data on Tuesday, April, 29th. The medical research company reported $3.84 EPS for the quarter, beating analysts' consensus estimates of $3.73 by $0.11. The company's quarterly revenue was up 5.3% compared to the same quarter last year.
Read the conference call transcript
.

Labcorp subsidiaries include these companies: Clinical Outreach Laboratory Services, Personal Genome Diagnostics Inc., Toxikon Corporation, Myriad Autoimmune’s Vectra Testing Business, Ovia Health, Visiun, Envigo's nonclinical contract research services business, and others.

Labcorp's top institutional investors include Czech National Bank (0.02%), Fragasso Financial Advisors Inc (0.01%), Baker Ellis Asset Management LLC (0.01%) and Delphi Management Inc. MA (0.01%). Insiders that own company stock include Adam H Schechter, Glenn A Eisenberg, Brian J Caveney, Lance Berberian, Paul R Kirchgraber, Kerrii B Anderson, Dwight Gary Gilliland, Amy B Summy, Mark S Schroeder, Jonathan P Divincenzo, Der Vaart Sandra D Van and Peter J Wilkinson.
View institutional ownership trends
.

Shares of LH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Labcorp investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Adobe (ADBE), ServiceNow (NOW) and Arista Networks (ANET).

Company Calendar

Last Earnings
4/29/2025
Record date for 6/11 Dividend
5/29/2025
Dividend Payable
6/11/2025
Today
7/09/2025
Next Earnings (Estimated)
7/24/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Medical Services
Sub-Industry
Health Care Services
Current Symbol
NYSE:LH
Previous Symbol
NYSE:LH?
CIK
920148
Employees
70,000
Year Founded
1995

Price Target and Rating

High Price Target
$300.00
Low Price Target
$230.00
Potential Upside/Downside
+7.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.79
Research Coverage
14 Analysts

Profitability

Trailing P/E Ratio
29.99
Forward P/E Ratio
16.21
P/E Growth
1.63
Net Income
$746 million
Pretax Margin
7.11%

Debt

Sales & Book Value

Annual Sales
$13.01 billion
Cash Flow
$22.58 per share
Price / Cash Flow
11.49
Book Value
$96.27 per share
Price / Book
2.70

Miscellaneous

Free Float
82,997,000
Market Cap
$21.72 billion
Optionable
Optionable
Beta
0.82

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NYSE:LH) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners